BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 29, 2002
View Archived Issues
Novel dual mechanism of action reported for CP-248
Read More
K(ATP) channel opener KCO-912 effective against allergen-induced airways hyperresponsiveness
Read More
Medarex acquires anticancer and immunotherapeutic programs from Corixa
Read More
AUA presentations discuss use of tamsulosin for BPH
Read More
Monoamine reuptake inhibitors claimed by Lilly
Read More
Welfide describes novel C5a antagonists
Read More
Tachykinin antagonists and their use described by Takeda
Read More
Novel antiarrhythmic agent claimed by AstraZeneca
Read More
G-CSF-like compounds in the SSP pipeline
Read More
Inhibitors of 5alpha-reductase highlighted at the AUA meeting
Read More
New approaches to bladder cancer management discussed in Orlando this week
Read More
Antitumor effects of COX and 5-LO inhibitors under evaluation by several research groups
Read More
Data from basic and clinical studies on prostate cancer reported at AUA
Read More
Lovastatin may be useful in airways disorders
Read More
New data on PPARgamma ligands presented at the ATS conference
Read More
Clinical efficacy of oral pirfenidone as a treatment for pulmonary fibrosis
Read More
Inhibitors of phosphate transport and their use in renal failure, etc.
Read More
Sankyo patents triglyceride-lowering agents
Read More
Antiasthmatic NK2 antagonists in early development at Nippon Kayaku
Read More
Eligard 7.5 mg launched for advanced prostate cancer
Read More
Ethypharm licenses U.S. rights to twice-daily morphine sulfate to aaiPharma
Read More
MRA completes phase II trial in rheumatoid arthritis
Read More
Ethypharm and Aventis collaborate to create Flash version of Allegra
Read More
ATS presentations describe efficacy of statin in pulmonary hypertension
Read More
Synagis approved in Canada for RSV-induced lower respiratory tract disease
Read More
Merck & Co. to develop Taisho's mGluR agonists for CNS disorders
Read More
Ebixa approved in E.U. for Alzheimer's disease
Read More